Michael Noel Cocchi, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Out-of-Hospital Cardiac Arrest | 20 | 2024 | 340 | 3.040 |
Why?
|
Heart Arrest | 30 | 2024 | 1516 | 2.870 |
Why?
|
Lactic Acid | 15 | 2024 | 1140 | 1.820 |
Why?
|
Cardiopulmonary Resuscitation | 27 | 2024 | 997 | 1.640 |
Why?
|
Shock, Septic | 13 | 2023 | 774 | 1.620 |
Why?
|
Thiamine | 11 | 2024 | 160 | 1.420 |
Why?
|
Ubiquinone | 5 | 2021 | 183 | 1.190 |
Why?
|
Hypothermia, Induced | 11 | 2021 | 756 | 1.010 |
Why?
|
Cytochromes c | 4 | 2019 | 173 | 1.010 |
Why?
|
Rewarming | 4 | 2021 | 64 | 0.930 |
Why?
|
Shock | 4 | 2019 | 316 | 0.930 |
Why?
|
Vasoconstrictor Agents | 7 | 2022 | 657 | 0.890 |
Why?
|
Intensive Care Units | 13 | 2023 | 3800 | 0.850 |
Why?
|
Propanolamines | 1 | 2022 | 164 | 0.760 |
Why?
|
Hospital Mortality | 19 | 2021 | 5367 | 0.650 |
Why?
|
Patient Transfer | 4 | 2021 | 793 | 0.590 |
Why?
|
Sepsis | 11 | 2018 | 2601 | 0.560 |
Why?
|
Angiotensin II | 1 | 2019 | 846 | 0.530 |
Why?
|
Balloon Occlusion | 1 | 2017 | 131 | 0.530 |
Why?
|
Esophageal and Gastric Varices | 1 | 2017 | 214 | 0.480 |
Why?
|
Teaching Rounds | 1 | 2018 | 282 | 0.450 |
Why?
|
Pyruvate Dehydrogenase Complex | 4 | 2024 | 64 | 0.430 |
Why?
|
APACHE | 2 | 2012 | 268 | 0.420 |
Why?
|
Body Temperature | 6 | 2021 | 781 | 0.410 |
Why?
|
Interdisciplinary Communication | 1 | 2018 | 937 | 0.410 |
Why?
|
Micronutrients | 1 | 2015 | 390 | 0.400 |
Why?
|
Critical Care | 8 | 2022 | 2716 | 0.390 |
Why?
|
Bacterial Infections | 1 | 2020 | 1397 | 0.380 |
Why?
|
Respiratory Insufficiency | 6 | 2017 | 1241 | 0.360 |
Why?
|
Resuscitation | 2 | 2022 | 679 | 0.350 |
Why?
|
Catheterization, Central Venous | 1 | 2015 | 536 | 0.350 |
Why?
|
Antihypertensive Agents | 1 | 2019 | 2027 | 0.340 |
Why?
|
Brain Edema | 2 | 2014 | 607 | 0.340 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2017 | 1126 | 0.330 |
Why?
|
Hypothermia | 1 | 2011 | 188 | 0.320 |
Why?
|
Severity of Illness Index | 11 | 2022 | 15939 | 0.320 |
Why?
|
Fever | 2 | 2013 | 1620 | 0.310 |
Why?
|
Transportation of Patients | 2 | 2021 | 176 | 0.290 |
Why?
|
Middle Aged | 65 | 2024 | 223463 | 0.280 |
Why?
|
Ascorbic Acid | 2 | 2020 | 658 | 0.260 |
Why?
|
Neuromuscular Blockade | 2 | 2020 | 148 | 0.260 |
Why?
|
Humans | 100 | 2024 | 768298 | 0.250 |
Why?
|
Pandemics | 3 | 2021 | 8750 | 0.250 |
Why?
|
Aged | 55 | 2024 | 171544 | 0.250 |
Why?
|
Male | 73 | 2024 | 364870 | 0.240 |
Why?
|
Fluid Therapy | 2 | 2015 | 585 | 0.240 |
Why?
|
Intracranial Hemorrhages | 1 | 2010 | 811 | 0.230 |
Why?
|
Prospective Studies | 24 | 2021 | 54921 | 0.230 |
Why?
|
Adrenergic beta-Agonists | 2 | 2016 | 347 | 0.220 |
Why?
|
Urinary Tract Infections | 2 | 2023 | 806 | 0.220 |
Why?
|
Intuition | 1 | 2003 | 20 | 0.210 |
Why?
|
Respiration, Artificial | 5 | 2021 | 2721 | 0.210 |
Why?
|
Thiamine Deficiency | 2 | 2016 | 48 | 0.210 |
Why?
|
Female | 69 | 2024 | 397050 | 0.200 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2010 | 1039 | 0.200 |
Why?
|
Retrospective Studies | 28 | 2023 | 81768 | 0.200 |
Why?
|
Coma | 2 | 2017 | 487 | 0.190 |
Why?
|
Epinephrine | 2 | 2016 | 795 | 0.190 |
Why?
|
Acidosis, Lactic | 3 | 2013 | 146 | 0.190 |
Why?
|
Emergency Medical Services | 4 | 2018 | 1946 | 0.190 |
Why?
|
Survival Analysis | 7 | 2020 | 10117 | 0.180 |
Why?
|
Interleukins | 2 | 2016 | 795 | 0.180 |
Why?
|
Diabetic Ketoacidosis | 2 | 2016 | 255 | 0.180 |
Why?
|
Catheter-Related Infections | 1 | 2023 | 275 | 0.180 |
Why?
|
Adrenal Cortex Hormones | 2 | 2020 | 1890 | 0.180 |
Why?
|
Double-Blind Method | 9 | 2024 | 12457 | 0.170 |
Why?
|
Neuromuscular Nondepolarizing Agents | 1 | 2020 | 145 | 0.170 |
Why?
|
Tachycardia | 1 | 2022 | 598 | 0.170 |
Why?
|
Hypertension | 1 | 2019 | 8615 | 0.170 |
Why?
|
Norepinephrine | 1 | 2022 | 900 | 0.160 |
Why?
|
Emergency Service, Hospital | 13 | 2020 | 7955 | 0.160 |
Why?
|
Myocardial Infarction | 1 | 2020 | 11515 | 0.160 |
Why?
|
Leukocytes, Mononuclear | 2 | 2016 | 1855 | 0.160 |
Why?
|
Cross Infection | 3 | 2023 | 1422 | 0.150 |
Why?
|
Health Care Rationing | 1 | 2022 | 435 | 0.150 |
Why?
|
Catecholamines | 1 | 2019 | 390 | 0.150 |
Why?
|
Acute Kidney Injury | 2 | 2023 | 1943 | 0.150 |
Why?
|
Stroke | 2 | 2019 | 9742 | 0.150 |
Why?
|
Cytokines | 2 | 2016 | 7443 | 0.150 |
Why?
|
Multiple Organ Failure | 1 | 2020 | 387 | 0.150 |
Why?
|
Vital Signs | 2 | 2017 | 144 | 0.150 |
Why?
|
Perioperative Care | 2 | 2015 | 1045 | 0.150 |
Why?
|
Tidal Volume | 2 | 2017 | 515 | 0.140 |
Why?
|
Resuscitation Orders | 1 | 2019 | 271 | 0.140 |
Why?
|
Referral and Consultation | 2 | 2022 | 3627 | 0.140 |
Why?
|
Standard of Care | 1 | 2022 | 570 | 0.140 |
Why?
|
Treatment Failure | 3 | 2020 | 2664 | 0.140 |
Why?
|
Logistic Models | 8 | 2016 | 13323 | 0.140 |
Why?
|
Prognosis | 7 | 2019 | 30020 | 0.130 |
Why?
|
Creatinine | 2 | 2023 | 1915 | 0.130 |
Why?
|
Aged, 80 and over | 24 | 2021 | 59683 | 0.130 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2017 | 192 | 0.130 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 646 | 0.130 |
Why?
|
American Heart Association | 3 | 2015 | 1051 | 0.130 |
Why?
|
Documentation | 1 | 2022 | 917 | 0.120 |
Why?
|
Disease Management | 4 | 2019 | 2536 | 0.120 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2015 | 692 | 0.120 |
Why?
|
Nervous System Diseases | 3 | 2017 | 1664 | 0.120 |
Why?
|
Survivors | 4 | 2017 | 2382 | 0.120 |
Why?
|
Unnecessary Procedures | 1 | 2018 | 419 | 0.120 |
Why?
|
Patient Care Team | 2 | 2018 | 2529 | 0.120 |
Why?
|
Pulse | 1 | 2014 | 218 | 0.120 |
Why?
|
Practice Guidelines as Topic | 5 | 2019 | 7453 | 0.120 |
Why?
|
Wounds and Injuries | 1 | 2007 | 2513 | 0.120 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 357 | 0.120 |
Why?
|
Advanced Cardiac Life Support | 1 | 2014 | 79 | 0.120 |
Why?
|
Adult | 30 | 2021 | 223622 | 0.110 |
Why?
|
Coronary Artery Bypass | 2 | 2016 | 2194 | 0.110 |
Why?
|
Treatment Outcome | 15 | 2021 | 65365 | 0.110 |
Why?
|
Medicine | 1 | 2022 | 948 | 0.110 |
Why?
|
Mouth Floor | 1 | 2013 | 39 | 0.110 |
Why?
|
Predictive Value of Tests | 10 | 2017 | 15455 | 0.110 |
Why?
|
ROC Curve | 4 | 2017 | 3622 | 0.110 |
Why?
|
Venous Thrombosis | 1 | 2003 | 1317 | 0.110 |
Why?
|
Judgment | 1 | 2015 | 272 | 0.110 |
Why?
|
Patient Admission | 1 | 2020 | 1367 | 0.110 |
Why?
|
Eating | 1 | 2020 | 1541 | 0.110 |
Why?
|
Boston | 3 | 2022 | 9371 | 0.100 |
Why?
|
Withholding Treatment | 1 | 2016 | 620 | 0.100 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2017 | 621 | 0.100 |
Why?
|
Registries | 7 | 2017 | 8378 | 0.100 |
Why?
|
Arrhythmias, Cardiac | 1 | 2022 | 2258 | 0.100 |
Why?
|
Physicians | 2 | 2020 | 4614 | 0.100 |
Why?
|
Leadership | 1 | 2021 | 1395 | 0.100 |
Why?
|
Hot Temperature | 1 | 2018 | 1440 | 0.100 |
Why?
|
Survival Rate | 5 | 2017 | 12870 | 0.100 |
Why?
|
Family | 2 | 2022 | 3208 | 0.100 |
Why?
|
Residence Characteristics | 1 | 2022 | 2122 | 0.100 |
Why?
|
Vitamin B Complex | 2 | 2024 | 299 | 0.100 |
Why?
|
Hydrocortisone | 2 | 2018 | 1841 | 0.100 |
Why?
|
Pneumonia, Bacterial | 1 | 2014 | 319 | 0.090 |
Why?
|
Hemodynamics | 1 | 2022 | 4199 | 0.090 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 871 | 0.090 |
Why?
|
Pilot Projects | 5 | 2016 | 8730 | 0.090 |
Why?
|
Arctic Regions | 1 | 2011 | 25 | 0.090 |
Why?
|
Critical Illness | 3 | 2023 | 2755 | 0.090 |
Why?
|
Myoclonus | 1 | 2011 | 107 | 0.090 |
Why?
|
Artifacts | 1 | 2020 | 1930 | 0.090 |
Why?
|
Academic Medical Centers | 2 | 2018 | 2783 | 0.090 |
Why?
|
Respiratory Rate | 1 | 2012 | 180 | 0.090 |
Why?
|
Regional Health Planning | 1 | 2011 | 96 | 0.090 |
Why?
|
Anti-Bacterial Agents | 3 | 2020 | 7458 | 0.090 |
Why?
|
C-Reactive Protein | 1 | 2022 | 3859 | 0.090 |
Why?
|
Cohort Studies | 9 | 2018 | 41791 | 0.090 |
Why?
|
Inpatients | 2 | 2019 | 2569 | 0.080 |
Why?
|
Critical Pathways | 1 | 2013 | 476 | 0.080 |
Why?
|
Neuroprotective Agents | 1 | 2016 | 957 | 0.080 |
Why?
|
Quality Improvement | 2 | 2022 | 3858 | 0.080 |
Why?
|
Electrocardiography | 2 | 2020 | 6409 | 0.080 |
Why?
|
Flank Pain | 1 | 2009 | 44 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1280 | 0.080 |
Why?
|
United States | 15 | 2020 | 73144 | 0.080 |
Why?
|
Calibration | 1 | 2011 | 823 | 0.080 |
Why?
|
Time Factors | 8 | 2019 | 40267 | 0.080 |
Why?
|
Microcirculation | 1 | 2013 | 1282 | 0.080 |
Why?
|
Death, Sudden, Cardiac | 1 | 2016 | 1568 | 0.080 |
Why?
|
Body Temperature Regulation | 2 | 2021 | 292 | 0.070 |
Why?
|
Electric Countershock | 3 | 2016 | 534 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2016 | 4357 | 0.070 |
Why?
|
Models, Organizational | 1 | 2011 | 548 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3707 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2016 | 3520 | 0.070 |
Why?
|
Hospitals, Teaching | 1 | 2012 | 1155 | 0.070 |
Why?
|
Hospitalization | 4 | 2023 | 10844 | 0.070 |
Why?
|
Positive-Pressure Respiration | 1 | 2012 | 713 | 0.070 |
Why?
|
Influenza, Human | 1 | 2018 | 1539 | 0.070 |
Why?
|
Cannabinoids | 1 | 2009 | 175 | 0.070 |
Why?
|
Area Under Curve | 1 | 2011 | 1642 | 0.070 |
Why?
|
Bacteremia | 2 | 2012 | 985 | 0.070 |
Why?
|
Nausea | 1 | 2009 | 682 | 0.070 |
Why?
|
Leukocyte Count | 1 | 2010 | 1605 | 0.070 |
Why?
|
Kidney | 2 | 2023 | 7063 | 0.070 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2010 | 359 | 0.070 |
Why?
|
Vomiting | 1 | 2009 | 655 | 0.070 |
Why?
|
Cholesterol | 1 | 2015 | 2912 | 0.070 |
Why?
|
Cause of Death | 1 | 2016 | 3728 | 0.060 |
Why?
|
Quality of Health Care | 2 | 2019 | 4339 | 0.060 |
Why?
|
Recovery of Function | 2 | 2017 | 2990 | 0.060 |
Why?
|
Shock, Hemorrhagic | 1 | 2007 | 224 | 0.060 |
Why?
|
Coronary Angiography | 1 | 2017 | 4537 | 0.060 |
Why?
|
Patient Discharge | 3 | 2015 | 3474 | 0.060 |
Why?
|
Emergency Medicine | 1 | 2014 | 1222 | 0.060 |
Why?
|
Marijuana Abuse | 1 | 2009 | 410 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4265 | 0.060 |
Why?
|
Hospitals, Urban | 3 | 2012 | 500 | 0.060 |
Why?
|
Recurrence | 1 | 2017 | 8501 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8902 | 0.060 |
Why?
|
Oxygen Consumption | 2 | 2024 | 1882 | 0.060 |
Why?
|
Infusions, Intravenous | 2 | 2020 | 2226 | 0.050 |
Why?
|
Mitochondria | 1 | 2017 | 3675 | 0.050 |
Why?
|
Vitamins | 1 | 2011 | 1638 | 0.050 |
Why?
|
Urinary Catheterization | 1 | 2023 | 195 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3118 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39405 | 0.050 |
Why?
|
Length of Stay | 2 | 2015 | 6516 | 0.050 |
Why?
|
Cerebrovascular Circulation | 1 | 2011 | 2736 | 0.050 |
Why?
|
Incidence | 3 | 2016 | 21544 | 0.050 |
Why?
|
Advisory Committees | 2 | 2015 | 797 | 0.050 |
Why?
|
Catheters, Indwelling | 1 | 2023 | 436 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2016 | 15854 | 0.040 |
Why?
|
Prone Position | 1 | 2021 | 203 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2014 | 20766 | 0.040 |
Why?
|
Hypernatremia | 1 | 2020 | 78 | 0.040 |
Why?
|
Internationality | 2 | 2015 | 1008 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 4047 | 0.040 |
Why?
|
Hypotension | 2 | 2017 | 889 | 0.040 |
Why?
|
Cardiology | 1 | 2011 | 1701 | 0.040 |
Why?
|
Disease Progression | 1 | 2017 | 13646 | 0.040 |
Why?
|
Monitoring, Physiologic | 1 | 2007 | 1795 | 0.040 |
Why?
|
Hyperglycemia | 2 | 2020 | 1389 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6319 | 0.040 |
Why?
|
Prevalence | 4 | 2015 | 15868 | 0.040 |
Why?
|
Propensity Score | 2 | 2017 | 1955 | 0.040 |
Why?
|
Health Priorities | 1 | 2022 | 380 | 0.040 |
Why?
|
Clinical Competence | 1 | 2014 | 4847 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2018 | 2862 | 0.040 |
Why?
|
Organizational Case Studies | 1 | 2019 | 301 | 0.040 |
Why?
|
Risk Factors | 5 | 2017 | 74954 | 0.040 |
Why?
|
Risk Assessment | 2 | 2017 | 24316 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2011 | 3008 | 0.040 |
Why?
|
Intention | 1 | 2020 | 348 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2011 | 3252 | 0.040 |
Why?
|
Probability | 1 | 2003 | 2482 | 0.040 |
Why?
|
Ribonuclease P | 1 | 2017 | 18 | 0.040 |
Why?
|
Specialization | 1 | 2022 | 781 | 0.030 |
Why?
|
Medical Futility | 1 | 2018 | 136 | 0.030 |
Why?
|
Inflammation | 2 | 2018 | 10863 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2022 | 718 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12092 | 0.030 |
Why?
|
Regression Analysis | 2 | 2017 | 6350 | 0.030 |
Why?
|
Protective Agents | 1 | 2017 | 150 | 0.030 |
Why?
|
Environmental Exposure | 1 | 2011 | 4528 | 0.030 |
Why?
|
Partial Pressure | 1 | 2015 | 248 | 0.030 |
Why?
|
Pulmonary Embolism | 1 | 2009 | 2587 | 0.030 |
Why?
|
Japan | 1 | 2019 | 1418 | 0.030 |
Why?
|
Acute Disease | 2 | 2018 | 7242 | 0.030 |
Why?
|
Young Adult | 6 | 2021 | 60048 | 0.030 |
Why?
|
Blood Gas Analysis | 1 | 2015 | 384 | 0.030 |
Why?
|
Comorbidity | 3 | 2017 | 10588 | 0.030 |
Why?
|
Internship and Residency | 1 | 2014 | 5948 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 26373 | 0.030 |
Why?
|
Cardiac Care Facilities | 1 | 2013 | 35 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2020 | 12557 | 0.030 |
Why?
|
Professional-Patient Relations | 1 | 2018 | 726 | 0.030 |
Why?
|
PubMed | 1 | 2013 | 130 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2011 | 5375 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3439 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2017 | 1195 | 0.030 |
Why?
|
Oximetry | 1 | 2015 | 462 | 0.030 |
Why?
|
Lactates | 1 | 2013 | 401 | 0.030 |
Why?
|
Nursing Homes | 1 | 2019 | 1084 | 0.020 |
Why?
|
Perception | 1 | 2018 | 1206 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2397 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2017 | 2363 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2014 | 473 | 0.020 |
Why?
|
Self Efficacy | 1 | 2014 | 643 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2877 | 0.020 |
Why?
|
Hospitals, University | 1 | 2012 | 568 | 0.020 |
Why?
|
Ultrasonography | 1 | 2003 | 6001 | 0.020 |
Why?
|
Urban Health Services | 1 | 2010 | 177 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2016 | 1894 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14736 | 0.020 |
Why?
|
Qualitative Research | 1 | 2019 | 3131 | 0.020 |
Why?
|
Observation | 1 | 2010 | 311 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2016 | 22292 | 0.020 |
Why?
|
Communication | 1 | 2022 | 3912 | 0.020 |
Why?
|
Educational Measurement | 1 | 2014 | 1256 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2017 | 1802 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1891 | 0.020 |
Why?
|
Consensus | 1 | 2016 | 3212 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2017 | 2240 | 0.020 |
Why?
|
Emotions | 1 | 2018 | 2768 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2931 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3412 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2018 | 3485 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5878 | 0.020 |
Why?
|
Reference Values | 1 | 2012 | 4941 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3921 | 0.010 |
Why?
|
Health Status | 1 | 2017 | 4094 | 0.010 |
Why?
|
Liver Diseases | 1 | 2012 | 1301 | 0.010 |
Why?
|
Hippocampus | 1 | 2016 | 3784 | 0.010 |
Why?
|
Heart Rate | 1 | 2014 | 4218 | 0.010 |
Why?
|
Data Collection | 1 | 2012 | 3324 | 0.010 |
Why?
|
Risk | 1 | 2015 | 9635 | 0.010 |
Why?
|
Hospitals | 1 | 2016 | 3905 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9494 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2398 | 0.010 |
Why?
|
Adolescent | 2 | 2023 | 89182 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5830 | 0.010 |
Why?
|
Odds Ratio | 1 | 2012 | 9681 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10377 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20224 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18472 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 22355 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18358 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 13019 | 0.010 |
Why?
|
Mice | 1 | 2016 | 82004 | 0.000 |
Why?
|
Animals | 1 | 2016 | 169322 | 0.000 |
Why?
|